Andhra Pradesh, India

Pramanik Dipankar

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pramanik Dipankar. Retrieved from https://idiyas.com/inventor/pramanik-dipankar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pramanik Dipankar: Innovator in Cationic Lipopeptides

Introduction

Pramanik Dipankar is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of biotechnology, particularly in the synthesis of novel cationic lipopeptides. His work focuses on enhancing gene transfer properties, which has potential applications in cancer treatment.

Latest Patents

Pramanik Dipankar holds 1 patent for his innovative work. The patent describes the synthesis of a novel series of cationic lipopeptides with integrin-binding RGD functionalities. This invention also highlights the high L27 cell tropic gene transfer properties of these RGD-lipopeptides. Given that L27 cell surfaces contain overexpressed integrins, these lipopeptides are likely to find future applications in targeting anti-cancer genes and drugs to the endothelial cells of tumor vasculatures.

Career Highlights

Pramanik Dipankar is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in biotechnology. His work has garnered attention for its potential impact on cancer therapies.

Collaborations

He has collaborated with notable colleagues such as Bharat Kumar Majeti and Priya Prakash Karmali, contributing to a dynamic research environment.

Conclusion

Pramanik Dipankar's innovative work in the field of cationic lipopeptides showcases his commitment to advancing medical science. His contributions have the potential to significantly impact cancer treatment methodologies in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…